Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Advanced Medical Solutions Group plc    AMS   GB0004536594

ADVANCED MEDICAL SOLUTIONS GROUP PLC

(AMS)
My previous session
Most popular
  Report  
Delayed Quote. Delayed London Stock Exchange - 03/25 12:35:04 pm
319 GBp   +1.75%
03/13ADVANCED MEDICAL : Unaudited preliminary results
PU
2018ADVANCED MEDICAL : Management Change
PU
2018ADVANCED MEDICAL : Fix8 approved in Europe
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201620172018201920202021
Sales82,696,9103110119129
EBITDA22,129,530,831,734,237,7
Operating profit (EBIT)19,525,428,628,430,833,5
Pre-Tax Profit (EBT)19,125,328,827,529,833,7
Net income15,720,122,721,823,926,7
P/E ratio30,033,926,230,628,325,7
EPS (GBp )7,389,3610,510,211,112,2
Dividend per Share (GBp )0,921,101,321,341,451,65
Yield0,41%0,35%0,48%0,43%0,46%0,53%
Reference price (GBp )221.75317.75275313.5313.5313.5
Announcement Date03/14/2017
07:52am
03/14/2018
06:01am
03/13/2019
07:01am
---
Finances - Leverage
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201620172018201920202021
Debt------
Finance51,162,576,484,8104127
Operating income (EBITDA)22,129,530,831,734,237,7
Leverage
(Debt/EBITDA)
------
Capital Expenditure1,522,903,063,383,201,50
Book Value Per Share (BVPS)59,1 PNC71,7 PNC81,0 PNC86,6 PNC91,8 PNC92,5 PNC
Cash Flow per Share9,33 PNC7,92 PNC9,44 PNC8,09 PNC8,87 PNC-
Announcement Date03/14/2017
07:52am
03/14/2018
06:01am
03/13/2019
07:01am
---
Balance Sheet Analysis
Assessed data source :
© 2019 Thomson Reuters
Financial Ratios

Size 2019e 2020e
Capitalization 669 M GBP -
Entreprise Value (EV) 584 M GBP 565 M GBP
Valuation 2019e 2020e
P/E ratio (Price / EPS) 30,6x 28,3x
Capitalization / Revenue 6,08x 5,65x
EV / Revenue 5,31x 4,77x
EV / EBITDA 18,4x 16,5x
Yield (DPS / Price) 0,43% 0,46%
Price to book (Price / BVPS) 3,62x 3,41x
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) 25,8% 26,0%
operating Leverage (Delta EBIT / Delta Sales) - 1,07x
Net Margin (Net Profit / Revenue) 19,8% 20,2%
ROA (Net Profit / Asset) 11,3% 11,4%
ROE (Net Profit / Equities) 12,2% 12,2%
Rate of Dividend 13,1% 13,1%
Balance Sheet Analysis 2019e 2020e
CAPEX / CA   3,07% 2,70%
Cash Flow / Sales 15,7% 16,0%
Capital Intensity (Assets / Sales) 1,75x 1,77x
Financial Leverage (Net Debt / EBITDA) -2,67x -3,04x
EPS & Dividend